openPR Logo
Press release

Biological Safety Testing Products And Services Market New Trends, Growth Opportunities, Top Players And Forecast To 2033

Biological Safety Testing Products And Services Market Trends

Biological Safety Testing Products And Services Market Trends

The Business Research Company recently released a comprehensive report on the Global Biological Safety Testing Products And Services Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp

According to The Business Research Company's, The biological safety testing products and services market size has grown rapidly in recent years. It will grow from $4.77 billion in 2023 to $5.4 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to the prevalence of target diseases, rising production of next-generation biologics, growing demand for biologics, rise in adoption of testing tools, growth in the pharmaceutical and biotechnology industries, and rising emphasis on regulatory compliance.

The biological safety testing products and services market size is expected to see rapid growth in the next few years. It will grow to $8.93 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to rising importance of evaluating their safety and effectiveness in treating health problems, increasing development of new therapeutics and treatments, rising interest in developing cell and gene therapies, rising investments in the biopharmaceutical space, and rising government initiatives to promote biopharmaceutical safety. Major trends in the forecast period include technological advancements, increasing demand for bioburden testing, rising investments in biopharmaceuticals and biologics, regulatory compliance driving adoption, and mergers and acquisitions among key players.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

Market Drivers and Trends:

The growing demand for gene therapies is expected to propel the growth of the biological safety testing products and services market going forward. Gene therapy is a medical approach that uses genes to treat or prevent disease by replacing, modifying, or supplementing faulty genes. The increased investment and research related to gene mutation and supportive regulatory environments further accelerate innovation and expand gene therapeutic applications. Biological safety testing products and services in gene therapy ensure viral vectors and genetic materials are contaminant-free and safe to use. For instance, in January 2024, according to a published document by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, in quarter four, 2023, the number of gene therapies in Phase III clinical trials grew by 10%, the first quarterly increase of that type since quarter three, 2022. Therefore, the growing demand for gene therapies drives the market of biological safety testing products and services.

Major companies operating in the biological safety testing products and services market are developing rapid animal-free bacterial endotoxin testing to enhance patient safety and expedite drug development.? This innovative approach aims to reduce testing time and improve reliability without the use of animal-based products. For instance, in January 2024, Charles River Laboratories International, a US-based pharmaceutical and biotechnology company, introduced the Endosafe Trillium cartridge, which employs recombinant technology to detect and quantify endotoxins without using animal-derived materials. It is the first rapid animal-free bacterial endotoxin test that features a faster turnaround time and eliminates the need for animal-derived reagents, thus enhancing sustainability and ethical testing practices. This product aims to provide rapid, accurate results while reducing reliance on the traditional Limulus amebocyte lysate (LAL) derived from horseshoe crabs?.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest

Biological Safety Testing Products And Services Market 2024 Key Insights:

• The biological safety testing products and services market size is expected to see rapid growth in the next few years. It will grow to $8.93 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%.
• Impact Of Growing Gene Therapy Demand On Biological Safety Testing Market
• Innovative Advancements In Biological Safety Testing Products And Services
• North America was the largest region in the biological safety testing products and services market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=18258&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (https://www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biological Safety Testing Products And Services Market New Trends, Growth Opportunities, Top Players And Forecast To 2033 here

News-ID: 3730967 • Views:

More Releases from The Business research company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Biological

Biological Control Market Projected to Witness Massive Growth - Koppert Biologic …
Biological Control Market Snapshot The Biological Control Market is projected to reach USD 9.7 billion by 2032, growing at a CAGR of 9.4% from 2025 to 2032. Coherent Market Insights proudly presents its latest Biological Control Market Research Report, delivering a detailed examination of the U.S. Biological Control Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,
Biological and Chemical Indicators Market - Beyond Measure: Biological and Chemi …
Newark, New Castle, USA: The "Biological and Chemical Indicators Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological and Chemical Indicators Market: https://www.growthplusreports.com/report/biological-and-chemical-indicators-market/8887 This latest report researches the
Biological APIs Market - Biological APIs: The Driving Force Behind Cutting-Edge …
Newark, New Castle, USA: The "Biological APIs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological APIs Market: https://www.growthplusreports.com/report/biological-apis-market/8769 This latest report researches the industry structure, sales, revenue,
Human Immunoglobulin for Intravenous Injection Market demand and future scope wi …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global Human Immunoglobulin for Intravenous Injection. On the basis of historic growth analysis and current scenario of Human Immunoglobulin for Intravenous Injection place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from
Global Biological safety testing Market | Global Biological safety testing Indus …
Biologics are termed as those product that attained from living organism and feature a differentiate set of properties. The biologics want extreme safety from contamination thus biological safety testing is incorporate timely to make sure its safety quality and non-contamination of vaccines & biopharmaceuticals, along with comply with the bound rules applicable on it. A number of the foremost biological tests are sterility testing, bioburden testing, residual host contaminant detection
Meningococcal Infections Vaccine Market Insights, Forecast to 2025 : Sanofi-Past …
Researchmoz added Most up-to-date research on "Global Meningococcal Infections Vaccine Market Insights, Forecast to 2025" to its huge collection of research reports. This report studies the global market size of Meningococcal Infections Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Infections Vaccine in these regions. This research report categorizes the global Meningococcal Infections Vaccine market